ClariVest Asset Management’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.32M Hold
2024
Q2
$1.32M Buy
2024
Q1
$902K Buy
2023
Q4
$632K Buy
2023
Q3
$470K Hold
2023
Q2
$597K Buy
2023
Q1
$436K Sell
2022
Q4
$539K Sell
2022
Q3
$648K Hold
2022
Q2
$630K Buy